NCT03839706View on ClinicalTrials.gov

Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 22, 2018

Primary Completion Date

July 30, 2022

Study Completion Date

September 30, 2024

Conditions
Hepatocellular Carcinoma
Interventions
DEVICE

PET MRI

18F-Fluorodeoxyglucose Positron Emission Tomography combined with Primovist MRI

Trial Locations (1)

M5G 2N2

Toronto General Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03839706 - Relationship Between 18FDG PET/MRI Patterns and ctDNA to Predict HCC Recurrence After Liver Transplantation | Biotech Hunter | Biotech Hunter